Evidence map›Paper›PMID 40631915›Full record

ArticleAmerican journal of medical genetics. Part A2025

AP2M1 Is a Candidate Gene for Microcephaly and Intellectual Disability in 3q27.1 Deletions.

Russell Gear, Paul Kalitsis, Melissa Glass, Bertrand Isidor, Catherine Vincent-Delorme, Florence Petit, Judith M A Verhagen, Alexander Jorge, Ana Cristina Victorino Krepischi, Ikeoluwa Osei-Owusu and 7 more

Abstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Russell GearVictorian Clinical Genetics Services, Melbourne, Australia.ORCID 0000-0001-5378-6746
Paul KalitsisVictorian Clinical Genetics Services, Melbourne, Australia.ORCID 0000-0001-5569-0609
Melissa GlassVictorian Clinical Genetics Services, Melbourne, Australia.
Bertrand IsidorUniversity Hospital Nantes, Nantes, France.
Catherine Vincent-DelormeCentre Hospitalier Arras, Arras, France.
Florence PetitCentre Hospitalier Universitaire de Lille, Lille, France.ORCID 0000-0002-1368-1023
Judith M A VerhagenErasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.ORCID 0000-0002-0340-3433
Alexander JorgeHuman Genome and Stem-Cell Research Center, Institute of Biosciences, Department of Genetics and Evolutionary Biology, University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-2567-7360
Ana Cristina Victorino KrepischiHuman Genome and Stem-Cell Research Center, Institute of Biosciences, Department of Genetics and Evolutionary Biology, University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-2931-8605
Ikeoluwa Osei-OwusuProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, USA.ORCID 0000-0002-1429-3532
Eva MartinezProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, USA.
Anne O'Donnell-LuriaProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, USA.
Nicole de LeeuwRadboud University Medical Center, Nijmegen, the Netherlands.ORCID 0000-0002-9796-3342
Sarah RuggieroChildren's Hospital of Philadelphia, Philadelphia, USA.
Ingo HelbigChildren's Hospital of Philadelphia, Philadelphia, USA.ORCID 0000-0001-8486-0558
Francis DavidVictorian Clinical Genetics Services, Melbourne, Australia.
Natasha J BrownVictorian Clinical Genetics Services, Melbourne, Australia.ORCID 0000-0002-1822-9191

Funding

Broad Institute Mendelian Genomic Research CenterU01HG011755 · NHGRI · BROAD INSTITUTE, INC. · PI Anne O'Donnell-Luria, MICHAEL E TALKOWSKI · 2021 to 2026
$14.6M
A powerful web-based discovery platform for rare disease geneticsR01HG009141 · NHGRI · BROAD INSTITUTE, INC. · PI QUINLAN, AARON R, REHM, HEIDI L · 2017 to 2020
$2.9M
Chan Zuckerberg Initiative Donor-Advised Fund at the Silicon Valley Community Foundation 2020-224274Chan Zuckerberg Initiative Donor-Advised Fund at the Silicon Valley Community Foundation 2022-316726National Human Genome Research Institute (NHGRI) R01HG009141National Human Genome Research Institute (NHGRI) U01HG011755NHGRI NIH HHS R01 HG009141NHGRI NIH HHS U01 HG011755
6 · The paper itself

Abstract

Deletions of the 3q26.33q27.2 region appear to correlate with a distinct phenotype, although there are few reported cases. Here, we present seven previously unreported individuals carrying de novo 3q27 deletions (under 5 Mb), which include the AP2M1 (adaptor-related protein complex 2, mu-1 subunit) gene and summarize data from 12 previously reported cases from the literature. The overall cohort of 19 individuals demonstrates almost universal intrauterine growth restriction, intellectual disability, and post-natal microcephaly, along with common features of hypotonia, post-natal short stature, and facial dysmorphisms. Newly identified features include bicuspid aortic valve, atrial septal defect, congenital malformation of the mesentery, and metopic craniosynostosis, present in a subset of individuals. These seven newly identified individuals allow narrowing of the previously reported smallest region of overlap to 430 kb at 3q27.1. This region includes 20 protein coding genes. We propose AP2M1 as the most likely contributor to the neurodevelopmental phenotype, based on its predicted intolerance to haploinsufficiency, functional evidence in murine models, and similar phenotypes associated with other adaptor-protein-complex-family members. Furthermore, we report the first individual with a de novo loss-of-function nonsense single nucleotide variant in AP2M1 with neurodevelopmental features including severe epilepsy. We discuss the implications of this finding in the context of previously reported epileptic encephalopathy in individuals with the recurrent p.Arg170Trp variant in AP2M1. In conclusion, our study expands the phenotypic spectrum of 3q27 microdeletions and highlights the potential importance of AP2M1 in its clinical presentation.

Indexed as

Chromosomes, Human, Pair 3Intellectual DisabilityMicrocephalyAdolescentChildChild, PreschoolChromosome DeletionFemaleGenetic Association StudiesHumansInfantMalePhenotype3q26.33q27.23q27.1AP2M1deletionhaploinsufficiencyintellectual disabilityloss‐of‐functionmicrocephaly

Identifiers

PMID40631915
PMCPMC12286883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.